PRECISION BIOSCIENCES INC
Customers
1
0 disclosed
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Latest period
Dec 31, 2024
10-K filed 2026-03-12
Customers 1
Companies DTIL discloses as major customers, as a share of DTIL revenue. 0 active, 1 lapsed.
| Company | % of DTIL revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| TGTX TG THERAPEUTICS, INC. |
12% | $8.2M | FY 2024-12-31 | Lapsed Last seen 2024-12-31 |
10-K 2026-03-12 | |
Revenue from Prevail Therapeutics, Inc. (“Prevail”) and TG Therapeutics (as defined below) accounted for 77% and 12% of revenue during the year ended December 31, 2024, respectively. | ||||||
Alerts are coming
Get an email when DTIL's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.